Condor Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5M Sell
10,557
-3,385
-24% -$1.7M 0.42% 51
2025
Q4
$6.51M Sell
13,942
-241
-2% -$112K 0.53% 42
2025
Q3
$6.05M Sell
14,183
-183
-1% -$70.9K 0.5% 43
2025
Q2
$5.5M Sell
14,366
-240
-2% -$86.5K 0.48% 43
2025
Q1
$5.05M Sell
14,606
-26
-0.2% -$8.36K 0.47% 45
2024
Q4
$4.39M Sell
14,632
-237
-2% -$82.8K 0.39% 61
2024
Q3
$6.04M Buy
14,869
+62
+0.4% +$22.7K 0.54% 45
2024
Q2
$4.76M Sell
14,807
-502
-3% -$163K 0.46% 47
2024
Q1
$5.11M Sell
15,309
-206
-1% -$63K 0.5% 46
2023
Q4
$4.2M Buy
15,515
+429
+3% +$106K 0.45% 51
2023
Q3
$3.71M Buy
15,086
+279
+2% +$76.3K 0.45% 44
2023
Q2
$4.49M Buy
14,807
+15
+0.1% +$4.17K 0.54% 39
2023
Q1
$3.9M Sell
14,792
-656
-4% -$167K 0.49% 44
2022
Q4
$3.71M Sell
15,448
-7
-0% -$1.57K 0.46% 48
2022
Q3
$2.84M Buy
15,455
+238
+2% +$47.4K 0.37% 60
2022
Q2
$2.56M Buy
15,217
+175
+1% +$37.6K 0.33% 67
2022
Q1
$3.77M Buy
15,042
+229
+2% +$57.5K 0.42% 51
2021
Q4
$3.81M Sell
14,813
-132
-0.9% -$32.3K 0.41% 56
2021
Q3
$3.63M Sell
14,945
-526
-3% -$129K 0.39% 68
2021
Q2
$3.2M Sell
15,471
-714
-4% -$146K 0.35% 70
2021
Q1
$3.05M Sell
16,185
-306
-2% -$54K 0.36% 68
2020
Q4
$2.71M Sell
16,491
-136
-0.8% -$19.9K 0.34% 79
2020
Q3
$2.07M Sell
16,627
-552
-3% -$68.3K 0.3% 82
2020
Q2
$1.67M Sell
17,179
-36
-0.2% -$3.74K 0.26% 88
2020
Q1
$1.55M Buy
17,215
+336
+2% +$43.5K 0.29% 82
2019
Q4
$2.5M Sell
16,879
-142
-0.8% -$19.1K 0.37% 69
2019
Q3
$2.05M Buy
17,021
+71
+0.4% +$9.18K 0.32% 78
2019
Q2
$2.29M Buy
16,950
+453
+3% +$57.3K 0.36% 72
2019
Q1
$2.15M Sell
16,497
-353
-2% -$47.4K 0.35% 73
2018
Q4
$2.1M Sell
16,850
-181
-1% -$24.3K 0.38% 65
2018
Q3
$2.37M Buy
17,031
+347
+2% +$43.2K 0.43% 58
2018
Q2
$1.71M Buy
16,684
+342
+2% +$34.6K 0.33% 81
2018
Q1
$1.58M Sell
16,342
-63
-0.4% -$6.11K 0.34% 84
2017
Q4
$1.44M Buy
16,405
+1,177
+8% +$94.6K 0.29% 87
2017
Q3
$1.21M Buy
15,228
+1,824
+14% +$147K 0.24% 103
2017
Q2
$1.17M Buy
13,404
+483
+4% +$40.9K 0.25% 99
2017
Q1
$1.15M Sell
12,921
-557
-4% -$46.4K 0.25% 99
2016
Q4
$998K Sell
13,478
-397
-3% -$29.7K 0.22% 108
2016
Q3
$1.05M Sell
13,875
-178
-1% -$13.6K 0.24% 99
2016
Q2
$1.08M Sell
14,053
-594
-4% -$46.9K 0.26% 95
2016
Q1
$1.14M Buy
14,647
+52
+0.4% +$3.63K 0.28% 89
2015
Q4
$987K Buy
14,595
+139
+1% +$9.7K 0.24% 102
2015
Q3
$1.12M Buy
14,456
+116
+0.8% +$10.3K 0.29% 91
2015
Q2
$1.3M Sell
14,340
-75
-0.5% -$6.01K 0.31% 87
2015
Q1
$1.08M Buy
14,415
+329
+2% +$23.6K 0.26% 103
2014
Q4
$1.03M Sell
14,086
-203
-1% -$14.3K 0.28% 97
2014
Q3
$1.01M Buy
+14,289
New +$944K 0.28% 100

Other funds holding HCA

Condor Capital Management's HCA Position: Q1 2026 in Review

Condor Capital Management reduced its HCA Healthcare (HCA) stake by 24% in Q1 2026, selling an estimated $1.7M and leaving 10,557 shares worth $5M. The position accounts for 0.42% of the portfolio, ranked #51.

Condor Capital Management first reported a position in HCA in Q3 2014 and has held it in 47 quarters since. The position peaked at $6.51M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Condor Capital Management held 10,557 shares of HCA Healthcare worth $5M as of Q1 2026.
  • Condor Capital Management sold 3,385 HCA Healthcare shares in Q1 2026, an estimated $1.7M.
  • HCA Healthcare made up 0.42% of Condor Capital Management's portfolio in Q1 2026, its #51 holding.
  • Condor Capital Management first reported a position in HCA Healthcare in Q3 2014 and has held it in 47 quarters since.
  • Condor Capital Management's HCA Healthcare position peaked at $6.51M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Condor Capital Management's 13F filing for Q1 2026, filed 11 May 2026.